A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Schizophrenia Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.SCHRES.2006.08.021PMID 17059880
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia.

  2006influential reference
• A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

  2005cited by this paper
• Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.

  2005influential reference
• Effects of Low-Dose Risperidone and Low-Dose Zuclopenthixol on Cognitive Functions in First-Episode Drug-Naïve Schizophrenic Patients

  2004cited by this paper
• Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia.

  2004cited by this paper
• Identification of separable cognitive factors in schizophrenia.

  2004cited by this paper
• What's atypical about atypical antipsychotic drugs?

  2004cited by this paper
• Dose Response and Dose Equivalence of Antipsychotics

  2004cited by this paper
• A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.

  2004influential reference
• Normative Data for Determining Significance of Test–Retest Differences on Eight Common Neuropsychological Instruments

  2004cited by this paper
• Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.

  2004cited by this paper
• Cognitive deficits as treatment targets in schizophrenia.

  2004cited by this paper
• Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia.

  2004cited by this paper
• Atypical antipsychotic drugs improve cognition in schizophrenia.

  2003cited by this paper
• Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study

  2003cited by this paper
• The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings.

  2003cited by this paper
• Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol

  2003cited by this paper
• Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.

  2003influential reference
• Cognitive effects and antipsychotic treatment.

  2003cited by this paper
• Effects of oral procyclidine administration on cognitive functions in healthy subjects: implications for schizophrenia.

  2002cited by this paper
• Atypical, but Not Typical, Antipsychotic Drugs Increase Cortical Acetylcholine Release without an Effect in the Nucleus Accumbens or Striatum

  2002cited by this paper
• Procedural learning improvements after six weeks of clozapine treatment.

  2002cited by this paper
• Does cognitive function improve with quetiapine in comparison to haloperidol?

  2002influential reference
• Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.

  2002influential reference
• Another view of therapy for cognition in schizophrenia.

  2002cited by this paper
• Practice Effects on the WAIS-III Across 3- and 6-Month Intervals

  2002cited by this paper
• The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone.

  2002cited by this paper
• Test–retest bias, reliability, and regression equations for neuropsychological measures repeated over a 12–16-week period

  2001cited by this paper
• Evaluation of Practice Effects in Language and Spatial Processing Test Performance

  2001cited by this paper
• Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.

  2001influential reference
• Detecting change: A comparison of three neuropsychological methods, using normal and clinical samples.

  2001cited by this paper
• Clozapine Enhances Neurocognition and Clinical Symptomatology More Than Standard Neuroleptics

  2001influential reference
• Stability and course of neuropsychological deficits in schizophrenia.

  2001influential reference
• The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia.

  2001cited by this paper
• Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.

  2001cited by this paper
• Approaches to heterogeneity in meta‐analysis

  2001cited by this paper
• Procedural learning in schizophrenia: further consideration on the deleterious effect of neuroleptics.

  2000cited by this paper
• The acute effects of amisulpride (50 mg and 200 mg) and haloperidol (2 mg) on cognitive function in healthy elderly volunteers

  2000cited by this paper
• Effects of Atypical Neuroleptics on Sustained Attention Deficits in Schizophrenia

  2000influential reference
• Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

  2000cited by this paper
• Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

  2000cited by this paper
• Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.

  2000cited by this paper
• Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.

  2000influential reference
• Risperidone versus haloperidol on secondary memory: can newer medications aid learning?

  1999influential reference
• The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.

  1999cited by this paper
• Detecting significant change in neuropsychological test performance: A comparison of four models

  1999cited by this paper
• Antipsychotics from theory to practice: integrating clinical and basic data.

  1999cited by this paper
• Psychomotor, Cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic.

  1999cited by this paper
• A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia.

  1999influential reference
• Test–retest reliability and practice effects of Expanded Halstead–Reitan Neuropsychological Test Battery

  1999influential reference
• Practice effects during repeated administrations of memory tests with and without alternate forms.

  1998cited by this paper
• Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

  1998cited by this paper
• Fixed- and random-effects models in meta-analysis.

  1998cited by this paper
• Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

  1997cited by this paper
• The Effects of Risperidone vs Haloperidol on Cognitive Functioning in Treatment-Resistant Schizophrenia: The Trail Making Test

  1997influential reference
• Effects of acute administration of d-amphetamine and haloperidol on procedural learning in man

  1997cited by this paper
• Recent and remote memory dissociation: medication effects and hippocampal function in schizophrenia.

  1997cited by this paper
• Meta-Analysis of Experiments With Matched Groups or Repeated Measures Designs

  1996cited by this paper
• Differential Effects of D2- and D4-Blocking Neuroleptics on the Procedural Learning of Schizophrenic Patients

  1996cited by this paper
• Benton Controlled Oral Word Association Test: reliability and updated norms.

  1996cited by this paper
• What are the functional consequences of neurocognitive deficits in schizophrenia?

  1996cited by this paper
• The Handbook of Research Synthesis

  1995cited by this paper
• The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.

  1994influential reference
• Combining estimates of effect size.

  1994cited by this paper
• A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary

  1993cited by this paper
• Schizophrenia research.

  1993cited by this paper
• Variance imputation for overviews of clinical trials with continuous response.

  1992cited by this paper
• Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia.

  1989cited by this paper
• Anticholinergic Effects on Memory: Benztropine versus Amantadine

  1989cited by this paper

• Negative association between cognitive functioning and antipsychotic D2 receptor occupancy, affinity, and dose after first episode psychosis

  2026cites this paper
• Mapping the trajectory of psychotic symptoms and their interaction with antipsychotic treatment: a longitudinal network intervention study

  2025cites this paper
• The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review

  2024cites this paper
• Cognitive Effects of Reducing First-Generation Antipsychotic Dose Compared to Switching to Ziprasidone in Long-Stay Patients with Schizophrenia

  2024cites this paper
• Efficacy of Risperidone in Enhancing Cognitive Functions in Psychiatric Disorders: A Systematic Review and Meta-analysis

  2024cites this paper
• Psychosis superspectrum II: neurobiology, treatment, and implications

  2024cites this paper
• Antipsychotic Drugs and Cognitive Function: A Systematic Review and Pairwise Network Meta-Analysis.

  2024cites this paper
• Status of Type II vs. Type I Bipolar Disorder: Systematic Review with Meta-Analyses

  2023cites this paper
• Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis

  2023cites this paper
• Haloperidol versus second-generation antipsychotics on the cognitive performance of individuals with schizophrenia and related disorders: pairwise meta-analysis of randomized controlled trials

  2023cites this paper
• Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia

  2023cites this paper
• Antipsychotic drugs and their effects on cognitive function: protocol for a systematic review, pairwise, and network meta-analysis

  2023cites this paper
• Antipsychotic Drug Development: From Historical Evidence to Fresh Perspectives

  2022cites this paper
• Application of Nanooptics in Photographic Imagery and Medical Imaging

  2021cites this paper
• Dose-dependent effects of antipsychotics on efficacy and adverse effects in schizophrenia.

  2021cites this paper
• Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats

  2021cites this paper
• Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report

  2021cites this paper
• The Effect of Smartphone-Based Cognitive Training on the Functional/Cognitive Markers of Schizophrenia: A One-Year Randomized Study

  2020cites this paper
• Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial

  2020cites this paper
• Factors influencing recovery from mild traumatic brain injury

  2020cites this paper
• Differences in Executive Function Among Patients With Schizophrenia, Their Unaffected First-Degree Relatives, and Healthy Participants

  2020cites this paper
• Emerging 5-HT receptor antagonists for the treatment of Schizophrenia

  2020cites this paper
• Psychopathology, cognition and outcome in Dutch and immigrant first‐episode psychosis patients

  2019cites this paper
• Cognitive impairment in schizophrenia and depression: A comparison of stability and course

  2019cites this paper
• The influence of typical and atypical antipsychotics on neurocognitive functions in patients with psychotic disorders

  2019cites this paper
• [Cognitive disorders in schizophrenia].

  2019cites this paper
• Nonpharmacological treatment of dyscognition in schizophrenia: effects 
of aerobic exercise


  2019cites this paper
• Differential benefits of olanzapine on executive function in schizophrenia patients: Preliminary findings

  2019cites this paper
• Investigation into effects of chronic treatment with antipsychotics using a combination of behavioural and electrophysiological techniques

  2019influential citation
• La reserva cognitiva en el trastorno mental grave

  2019cites this paper
• The In fl uence of Typical and Atypical Antipsychotics on Neurocognitive Functions in Patients with Psychotic Disorders A

  2019cites this paper
• Pharmakotherapie und andere somatische Behandlungsverfahren (Modul 4a)

  2019cites this paper
• Cortical thickness correlates of cognitive performance in cognitively‐matched individuals with and without schizophrenia

  2019cites this paper
• The MIND-USA Study Modifying the Impact of ICU-Associated Neurological Dysfunction

  2018cites this paper
• Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment in rats

  2018cites this paper
• Non literal language comprehension in a large sample of first episode psychosis patients in adulthood.

  2018cites this paper
• Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness

  2018cites this paper
• Factors Associated With Short and Long Term Cognitive Changes in Patients With Sepsis

  2018cites this paper
• Neurosteroid pregnenolone sulfate, alone, and as augmentation of lurasidone or tandospirone, rescues phencyclidine‐induced deficits in cognitive function and social interaction

  2018influential citation
• Psychosocial functioning in first‐episode psychosis and associations with neurocognition, social cognition, psychotic and affective symptoms

  2017cites this paper
• Diabetes Knowledge Among Adults with Serious Mental Illness and Comorbid Diabetes Mellitus☆

  2017cites this paper
• Kognitive Störungen bei Schizophrenie

  2017cites this paper
• Prefrontal-Thalamic Anatomical Connectivity and Executive Cognitive Function in Schizophrenia.

  2017cites this paper
• Challenges and opportunities for the development of new antipsychotic drugs.

  2017cites this paper
• Leczenie zaburzeń funkcji poznawczych w schizofrenii Część II: Strategie farmakologiczne

  2016cites this paper
• Cognitive Remediation in Mental Health

  2016cites this paper
• Dopamine dynamics during emotional cognitive processing: Implications of the specific actions of clozapine compared with haloperidol.

  2016cites this paper
• Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial

  2016cites this paper
• Influence of Antipsychotic and Anticholinergic Loads on Cognitive Functions in Patients with Schizophrenia

  2016cites this paper
• Statistical approaches to harmonize data on cognitive measures in systematic reviews are rarely reported.

  2015cites this paper
• Aufmerksamkeits- und Arbeitsgedächtnisleistung nikotinabhängiger paranoid-schizophrener Patienten unter dem Einfluss von Nikotinkarenz bzw. -zufuhr sowie in Abhängigkeit der Affinität ihres Atypischen Antipsychotikums zum muskarinergen M1-Rezeptor

  2015cites this paper
• Second‐generation antipsychotic effect on cognition in patients with schizophrenia—a meta‐analysis of randomized clinical trials

  2015cites this paper
• Pharmacotherapy of cognition in schizophrenia

  2015cites this paper
• Verbal memory.

  2015cites this paper
• Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses

  2015cites this paper
• Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses

  2015cites this paper
• Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses

  2015cites this paper
• Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses

  2015cites this paper
• May Non-antipsychotic Drugs Improve Cognition of Schizophrenia Patients?

  2015cites this paper
• Cognitive performance during the first year of treatment in first-episode schizophrenia: a case–control study

  2015cites this paper
• Cognitive Enhancement

  2015cites this paper
• The longitudinal course of cognitive impairment in schizophrenia: an examination of data from premorbid through posttreatment phases of illness.

  2014cites this paper
• Psychotic symptoms, cognition and affect as predictors of psychosocial problems and functional change in first-episode psychosis.

  2014cites this paper
• Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis

  2014cites this paper
• Glutamate receptor 1 phosphorylation at serine 845 contributes to the therapeutic effect of olanzapine on schizophrenia-like cognitive impairments.

  2014cites this paper
• Auditory p300 event-related potentials in children with Sydenham's chorea.

  2014cites this paper
• Neuropsychological functioning of a patient with organic personality disorder.

  2014cites this paper
• Auditory P 300 event-related potentials in children with Sydenham ’ s chorea

  2014cites this paper
• Increased Prolactin Levels Are Associated with Impaired Processing Speed in Subjects with Early Psychosis

  2014cites this paper
• Funcionamiento neuropsicológico de un paciente con trastorno orgánico de la personalidad

  2014cites this paper
• Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone

  2013cites this paper
• Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: the potential impact of GABA concentration in the visual cortex.

  2013cites this paper
• Antipsychotic medications and cognitive functioning in bipolar disorder: moderating effects of COMT Val108/158 Met genotype

  2013cites this paper
• [The influence of antipsychotic therapy on the cognitive functions of schizophrenic patients].

  2013cites this paper
• Why negative meta-analyses may be false?

  2013cites this paper
• Executive function in eating disorders: the role of state anxiety.

  2013cites this paper
• COMT and MTHFR polymorphisms interaction on cognition in schizophrenia: an exploratory study.

  2013cites this paper
• Investigational drugs for schizophrenia targeting the dopamine receptor: Phase II trials

  2013cites this paper
• Cognitive effects of atypical antipsychotic drugs in first-episode drug-naïve schizophrenic patients

  2013cites this paper
• Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia.

  2013cites this paper
• Clinical Neuropsychology Within Adolescent and Young-Adult Psychiatry: Conceptualizing Theory and Practice

  2013cites this paper
• Effects of the neurotensin NTS₁ receptor agonist PD149163 on visual signal detection in rats.

  2013cites this paper
• Neurocognitive individualized training versus social skills individualized training: a randomized trial in patients with schizophrenia.

  2013cites this paper
• Harmonization of Cognitive Measures in Individual Participant Data and Aggregate Data Meta-Analysis

  2013cites this paper
• ' s response to reviews Title : Antipsychotic medications and cognitive functioning in bipolar disorder : moderating effects of COMT Val 108 / 158 Met genotype

  2013cites this paper
• [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].

  2013cites this paper
• Kognitive Remediation

  2013cites this paper
• Molecular and cellular pharmacology Effects of the neurotensin NTS 1 receptor agonist PD 149163 on visual signal detection in rats

  2013cites this paper
• Longitudinal changes in semantic categorization performance after symptomatic remission from first-episode psychosis: a 3-year follow-up study.

  2012cites this paper
• The effects of guided discontinuation of antipsychotics on neurocognition in first onset psychosis

  2012cites this paper
• Effect of Aripiprazole on Verbal Memory and Fluency in Schizophrenic Patients

  2012cites this paper
• Der Einfluss psychopharmakologischer Behandlung und klinischer Charakteristika auf die kognitive Verarbeitungsgeschwindigkeit bei Schizophrenie-Patienten - Ergebnisse aus der ELAN-Studie -

  2012cites this paper
• Developing treatments for impaired cognition in schizophrenia.

  2012cites this paper
• Cognitive deficits and ethnicity: a cohort study of early psychosis patients in The Netherlands

  2012cites this paper
• Safety of quetiapine fumarate extended release in the treatment of Korean patients with acute schizophrenia

  2012cites this paper
• Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients

  2012cites this paper
• Cognitive effects of a single dose of atypical antipsychotics in healthy volunteers compared with placebo or haloperidol.

  2012cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

  2012cites this paper
• HT1001, A Proprietary North American Ginseng Extract, Improves Working Memory in Schizophrenia: A Double‐blind, Placebo‐Controlled Study

  2012cites this paper
• Cognition and communication dysfunctions in early-onset schizophrenia: effect of risperidone.

  2012cites this paper